Jan 11 2025
A new study has revealed the potential of a cannabinoid-based dietary supplement, Pain ReliefTM, to significantly alleviate chronic pain and improve the quality of life in dogs suffering from osteoarthritis. Conducted by researchers from Columbia University, the University of Naples Federico II, and the University of Milano, the study was published in the peer-reviewed journal …
Jan 09 2025
Marijuana legalization does not correlate with an increase in employees using cannabis before or during work, according to a briefing paper from the Institute for Work & Health (IWH), a non-profit research organization. The study examined workers’ attitudes and behaviors in Canada following the legalization of adult-use marijuana in 2018. Researchers found no change in …
Jan 08 2025
Cannabichromene (CBC), a lesser-known cannabinoid found in marijuana, may offer therapeutic benefits for inflammatory skin conditions like atopic dermatitis (AD), according to new research published in the International Journal of Molecular Sciences. The study, conducted by researchers at The Catholic University of Korea, investigated CBC’s impact on AD using a 2,4-Dinitrochlorobenzene (DNCB)-induced BALB/c mouse model. …
Jan 08 2025
A study published in the journal Molecules highlights the potential of two cannabis-derived compounds, cannabinol (CBN) and cannabigerol (CBG), in combating acute myeloid leukemia. “Several cannabis plant-derived compounds, especially cannabinoids, exhibit therapeutic potential in numerous diseases and conditions”, states the study’s abstract. “In particular, THC and CBD impart palliative, antiemetic, as well as anticancer effects. …
Jan 06 2025
Mitragyna parvifolia leaves may serve as a therapeutic agent for lymphatic filariasis, according to a new study conducted by researchers from Madurai Kamaraj University and the Central University of Tamil Nadu in India. The study, published in the Journal of Parasitic Diseases, highlights the plant’s diverse bioactivity and underscores its potential for further research as …
Jan 06 2025
A study published in the journal Addiction by researchers from the University of Granada in Spain shows that vaporized cannabidiol (CBD) has little to no effect on visual function and driving performance. The randomized, double-blind, placebo-controlled crossover experiment assessed whether CBD impacts the ability to drive safely. The study involved 30 participants with an average …
Jan 05 2025
A new study published in the International Journal of Molecular Sciences investigates the potential of Mitragyna speciosa (commonly known as kratom) in addressing Alzheimer’s disease (AD), a neurodegenerative condition with limited treatment options. The research, conducted by teams from Walailak University in Thailand, the University of Kentucky, and the University of Chittagong in Bangladesh, employed …
Jan 03 2025
Researchers from the University of Alberta and Western Canada High School have conducted a study exploring the therapeutic potential of psilocybin in mitigating behavioral despair and cognitive impairments caused by chronic stress. Published in the peer reviewed journal Progress in Neuro-Psychopharmacology and Biological Psychiatry, the research focuses on the interaction between the Hypothalamic-Pituitary-Adrenal (HPA) axis …
Jan 03 2025
A single dose of psilocybin may offer relief for patients with severe treatment-resistant depression, according to an open-label study published in the American Journal of Psychiatry. The research, conducted by teams from Columbia University, Stanford University School of Medicine, and the University of Maryland, aimed to evaluate the safety and efficacy of psilocybin in individuals …
Jan 02 2025
According to the results of a new clinical trial, psilocybin holds promise as a tool for reshaping personality traits in people battling alcohol addiction. Researchers from New York University, the University of New Mexico School of Medicine, NYU Grossman School of Medicine, and Arizona State University conducted a randomized controlled trial to explore the effects …
